HOME >> MEDICINE >> NEWS
Synthetic progestin damages, estrogen protects blood vessels in animal model

TAMPA (11 Dec 2003) -- Synthetic progestins may be the major cause of harmful side effects reported with hormone replacement therapy. University of South Florida researchers used a novel imaging technique to show that progestins caused toxicity while natural progesterone and estrogen did not show toxicity to blood vessels in live animals.

"Our findings can lead to the development and screening of synthetic hormones to find a safe progestin that will ultimately give women safer options than are currently available for hormone replacement therapy," said Tom Thomas, MD, PhD, co-principal investigator and lead author of the study published today in Climacteric, the Journal of the International Menopause Society.

"This is experimental evidence that supports scientists who believe estrogen with the right formulation is good for some women, depending on their other risk factors."

The novel imaging technique was developed by Thomas and Johannes Rhodin, MD, PhD, co-principal investigator. It took three years for Thomas and Rhodin to combine video microscopy with fluorescence and electron microscopy. By labeling blood cells with a fluorescent tag, the team observed blood flow, blood vessel structure and activities of various blood cells in real time in a live animal. After one dose of medroxy progesterone acetate (MPA), the most widely used synthetic progestin in estrogen prepaparations and oral contraceptives, the rats had visible damage to the periphery and brain blood vessels, endothelial and smooth muscle damage, inflammation and blood clot formation and impeded blood flow.

These vascular reactions to synthetic progestin can lead to increases in heart attacks, blood clots, strokes and dementia--problems that were observed in the Women's Health Initiative," Thomas said.

The USF researchers' findings may shed light on the current reassessment of the National Institute of Health-sponsored Women's Health Initiative.

Using the sa
'"/>

Contact: Marissa Emerson
memerson@hsc.usf.edu
813-974-3300
University of South Florida Health
11-Dec-2003


Page: 1 2

Related medicine news :

1. Synthetic marijuana reduces agitation in patients with Alzheimers
2. Synthetic marijuana compound reduces agitation, improves appetite in Alzheimers patients
3. Synthetic rubber kills germs on contact
4. Views Of Tamoxifen And Synthetic Estrogen In Action Provide Clues For Designing Better Drugs
5. UCSF Study In Rats Suggests Synthetic Drug Mimicking Marijuana Might Be Used To Treat Pain
6. "Green Chemistry" Cleans Up Environment And Renders Synthetic Drugs
7. Synthetic Detergent Found To Fight Multi-Drug Resistance
8. Estrogren plus progestin decreases colorectal cancer in postmenopausal woman
9. High estrogen/progestin levels may reduce asthma severity, say Pittsburgh researchers
10. Changing chemistry helps explain estrogen threat to the heart
11. Use of estrogen therapy may increase risk for gallbladder disease

Post Your Comments:
(Date:9/4/2015)... Los Angeles, CA (PRWEB) , ... September 04, 2015 , ... ... new material has been developed that changes color when subjected to an impact force ... article notes, could be implemented in helmets or other sporting equipment so that coaches ...
(Date:9/4/2015)... ... September 04, 2015 , ... The Schmidt National Law Group ... La Paz. , Schmidt National Law Group, a leading firm in mass-tort litigation, ... against Bayer Corp., Bayer Essure, Inc., and other Bayer affiliates for injuries alleged to ...
(Date:9/4/2015)... ... September 04, 2015 , ... Inmar announced ... joint meeting of its Product, Quality and Manufacturers, Dietary Supplements and Supply Chain ... evolving in the consumer goods industry, it can be difficult for companies to ...
(Date:9/4/2015)... ... 2015 , ... “Getting away from the daily stressors and distractions of life ... their ‘couple-ness,’” says Jean Claude Wietzel, general manager at Four Seasons Resort Maui ... only Forbes Five Star resort and Travel + Leisure’s No. 1 Hotel in Hawaii, ...
(Date:9/4/2015)... ... 2015 , ... The conference program for the upcoming Integrative ... 2015 at the Diplomat Resort & Spa has been announced and is available ... the top of their field and will be presenting sessions such as What ...
Breaking Medicine News(10 mins):Health News:New Article on Head Injury Detection Technology Highlights Implications for Head Injury Detection in Sports, says The Law Offices of Burg & Brock 2Health News:Schmidt National Law Group Files First Bayer Essure® Lawsuit in California 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 3Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 3Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2
(Date:9/4/2015)... Future Prospects for Companies in Antihistamines, Corticosteroids, ... - new study showing you trends, partnerships, and ... allergic rhinitis drugs heading? What are the commercial prospects ... you potential revenues and other trends to 2025, discussing ... report provides 273 tables, charts, and graphs. Discover the ...
(Date:9/4/2015)... , Sep. 04, 2015 ... of the "Investigation Report on China,s Sodium Ibandronate Market, ... and used in the clinic under the trade name of ... Austria in 1996, sodium ibandronate was approved by ... treatment of osteoporosis under the trade name of Boniva. However, ...
(Date:9/4/2015)... September 4, 2015 Hutchison ... that Hutchison MediPharma Limited ("HMP"), its drug R&D ... second proof-of-concept ("POC") trial of fruquintinib in patients ... in China .  The top-line ... meeting the primary efficacy endpoint of progression free ...
Breaking Medicine Technology:Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7Investigation Report on China's Sodium Ibandronate Market 2010-2019 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 3
Cached News: